The addition of B-SM-IgA (%B) to the other 10 parameters did not change these subgroups, presumably because all but two of the PAD cohort were depleted of IgA-expressing switched memory B cells (data not shown); nevertheless, including this parameter may be important when analyzing PID cohorts not uniformly selected on the basis of antibody failure. This evidence concerns the gene CD79A and peripheral arterial disease.